Lilly to seek accelerated FDA approval for Alzheimer's drug this year

Lilly to seek accelerated FDA approval for Alzheimer's drug this year

on Also in , ,
Eli Lilly said on Thursday it will apply for U.S. health regulator's accelerated approval this year for its experimental Alzheimer's drug, weeks after Biogen Inc's (BIIB.O) controversial drug for the disease was approved.

Share:

Previous
Next

Comentarios

Publicar un comentario

Leave a comment. Thanks!

Comentarios de Facebook

Suscribirse a: Enviar comentarios (Atom)